Identifying Risk Factors for Female Cardiovascular Disease Patients in Malaysia: A Bayesian Approach by Nurliyana Juhan, et al.
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/330024786
Identifying Risk Factors for Female Cardiovascular Disease Patients in Malaysia:
A Bayesian Approach
Article · December 2018
DOI: 10.11113/matematika.v34.n3.1135
CITATIONS
0
READS
76
4 authors:
Some of the authors of this publication are also working on these related projects:
Remote Ischaemic Preconditioning View project
Circular statistics View project
Nurliyana Juhan
Universiti Malaysia Sabah (UMS)
11 PUBLICATIONS   6 CITATIONS   
SEE PROFILE
Yong Z Zubairi
University of Malaya
74 PUBLICATIONS   163 CITATIONS   
SEE PROFILE
Zarina Mohd Khalid
Universiti Teknologi Malaysia
19 PUBLICATIONS   12 CITATIONS   
SEE PROFILE
Ahmad Syadi Mahmood Zuhdi
University of Malaya
36 PUBLICATIONS   110 CITATIONS   
SEE PROFILE
All content following this page was uploaded by Nurliyana Juhan on 09 January 2019.
The user has requested enhancement of the downloaded file.
MATEMATIKA, 2018, Special Issue, 15–23
c© Penerbit UTM Press. All rights reserved
Identifying Risk Factors for Female Cardiovascular Disease Patients
in Malaysia: A Bayesian Approach
1,2Nurliyana Juhan∗, 3Yong Zulina Zubairi, 4Zarina Mohd Khalid
and 5Ahmad Syadi Mahmood Zuhdi
1,4Department of Mathematical Sciences, Faculty of Science
Universiti Teknologi Malaysia, 81310 Johor Bahru, Johor, Malaysia
2Preparatory Centre of Science and Technology,
Universiti Malaysia Sabah, 88400 Sabah, Malaysia
3Centre for Foundation Studies in Science,
University of Malaya, Kuala Lumpur, Malaysia
5Cardiology Unit,
University Malaya Medical Centre, 50603 Kuala Lumpur, Malaysia
∗Corresponding author: yzulina@um.edu.my
Article history
Received: 16 October 2018
Received in revised form: 4 December 2018
Accepted: 17 December 2018
Published on line: 31 December 2018
Abstract Cardiovascular disease (CVD) includes coronary heart disease, cerebrovascular
disease (stroke), peripheral artery disease, and atherosclerosis of the aorta. All females
face the threat of CVD. But becoming aware of symptoms and signs is a great challenge
since most adults at increased risk of cardiovascular disease (CVD) have no symptoms or
obvious signs especially in females. The symptoms may be identified by the assessment
of their risk factors. The Bayesian approach is a specific way in dealing with this kind
of problem by formalizing a priori beliefs and of combining them with the available ob-
servations. This study aimed to identify associated risk factors in CVD among female
patients presenting with ST Elevation Myocardial Infarction (STEMI) using Bayesian lo-
gistic regression and obtain a feasible model to describe the data. A total of 874 STEMI
female patients in the National Cardiovascular Disease Database-Acute Coronary Syn-
drome (NCVD-ACS) registry year 2006-2013 were analysed. Bayesian Markov Chain
Monte Carlo (MCMC) simulation approach was applied in the univariate and multivariate
analysis. Model performance was assessed through the model calibration and discrimina-
tion. The final multivariate model of STEMI female patients consisted of six significant
variables namely smoking, dyslipidaemia, myocardial infarction (MI), renal disease, Killip
class and age group. Females aged 65 years and above have higher incidence of CVD and
mortality is high among female patients with Killip class IV. Also, renal disease was a
strong predictor of CVD mortality. Besides, performance measures for the model was
considered good. Bayesian logistic regression model provided a better understanding on
the associated risk factors of CVD for female patients which may help tailor prevention
or treatment plans more effectively.
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1 Introduction
Cardiovascular disease (CVD) often be thought of as a health problem for males is the most
common cause of death for both males and females in Malaysia and worldwide [1,2]. CVD
includes coronary heart disease, cerebrovascular disease (stroke), peripheral artery disease, and
atherosclerosis of the aorta [3]. Most females have misperception that they are most likely to
die from cancer or breast cancer [3,4]. In reality, CVD poses a greater mortality threat than
breast cancer [5] and kills about 10 times more women than all cancers combined [6,7].
All females face the threat of CVD. But becoming aware of symptoms and signs is a great
challenge since most adults at increased risk of cardiovascular disease (CVD) have no symptoms
or obvious signs especially in females [8]. Additionally, some of the CVD symptoms in females
are different from those in males [9,10]. These may be identified by the assessment of the risk
factors.
The Bayesian approach is a specific way in dealing with this kind of problem by formaliz-
ing a priori beliefs and of combining them with the available observations. Bayesian approach
was introduced in medical research in 1982. However, its application in clinical research has
only been approved by the US Food and Drug Administration (FDA) in 2010 [11]. Bayesian
approach, which is learning from evidence as it accumulates, is now applied in all major ar-
eas of medical statistics, including clinical trials, epidemiology, and decision making for new
treatments or technologies.
Thus, this study aimed to identify associated risk factors in CVD among female patients
presenting with ST Elevation Myocardial Infarction (STEMI) in Malaysia using Bayesian lo-
gistic regression model and obtain the best model to describe the data. The organization of
this study is as such; it starts with a brief information on CVD and Bayesian approach. Next
is the results of proposed Bayesian logistic regression model and model overall fit. A discussion
and the implication of the findings of the analysis is given in the proceeding section.
2 Materials
In Malaysia, a registry supported by the Ministry of Health (MOH) known as the National
Cardiovascular Disease-Acute Coronary Syndrome (NCVD-ACS) registry, plays an important
role in collecting and providing information about CVD across Malaysia [12]. In this study,
a total of 874 female patients who were diagnosed with ST-elevation myocardial infarction
(STEMI) were selected from the NCVD-ACS registry for the years 2006 to 2013. Data was
collected from the time the female patient with STEMI was admitted to the hospital till 30
days post discharge.
Demographic variable such as patients’ ethnicity was divided into four major ethnic groups
namely Malay, Chinese, Indian and others. Age was categorized into two groups; age <65
years and age ≥ 65 years. The risk factors were diabetes mellitus, hypertension, smoking
status, dyslipidaemia and family history of CVD. While myocardial infarction (MI) history,
chronic lung disease, cerebrovascular disease, peripheral vascular disease and renal disease were
classified as the comorbid variables. Killip class as the clinical presentation was divided into
four classes. As for the treatment, the variables were percutaneous coronary intervention (PCI)
and cardiac catheterization.
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3 Methods
The Bayesian MCMC approach was applied to develop suitable models for CVD patients in
Malaysia. This approach, in short, is a way to associate the past (prior) with present (current
study) to make decisions about the future (posterior) [13]. Therefore, it was used to identify
significant risk factors and to obtain the posterior estimates of the proposed model.
For the Bayesian model in this study, likelihood for the outcome variable was defined as a lo-
gistic regression model with ”1” representing death and ”0” alive or otherwise. Mathematically,
logistic regression estimates a multiple linear regression function defined as:
logit(p) = log
(
p
1− p
)
= β0 + β1x1 + β2x2 + ...+ βnxn (1)
where p is the probability of presence of the characteristic of interest, βi is the logistic regression
coefficients and xi is the independent variables for i = 1, ..., n.
For the type of prior, non-informative prior was applied due to lack of information on the
regression parameters. Simulations were run for three multiple parallel chains with different
initial point for each of it.
Univariate analysis was performed on all variables using Bayesian MCMC approach. Vari-
ables that satisfied the screening criteria were then fitted into the Bayesian multivariate logistic
model. Results of the analysis were given in the form of odds ratio (OR) where it represents the
odds that an outcome will occur given a specific contact, compared to the odds of the outcome
occurring in the absence of that contact [14]. The standard error (SE) of the analysis were also
obtained. All the analysis were performed using JAGS, a software that applies Gibbs sampling
method in estimation of model parameters. The conditional distributions for βi were calculate
using the Gibbs sampling algorithm. The Gibbs sampling algorithm is used to generate an
instance from the distribution of each variable in turn, conditional on the current values of the
other variables [15]. Area under receiving operating characteristics curve (AUC) was used to
measure model discrimination [16], while Hosmer-Lemeshow test was used to measure model
calibration [17].
4 Results
Descriptive statistics was performed for female patients and the results are shown in Table 1.
Majority of the STEMI female patients were from ethnic Malay with more than 50% followed
by Chinese (20%) and Indian (19.9%). Predominantly, female patients fell into the less than
65-year-old age group. The most prevalence risk factor for STEMI female patients was hyper-
tension (74.5%), followed by diabetes mellitus (55.6%) and dyslipidaemia (35.8%) respectively.
Most of the STEMI patients were in Killip class I or II on presentation. As for the treatment,
cardiac catheterization was the most undergone procedure.
Bayesian univariate analysis are performed for female patients and seven variables are con-
sidered significant namely age group, smoking status, family history of CVD, dyslipidaemia,
MI history, renal disease and Killip class. The seven significant variables are then fitted into
Bayesian multivariate model.
From the Bayesian multivariate analysis shown in Table 2, six variables are observed to
be significantly associated with mortality of CVD female patients namely dyslipidaemia, MI
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Table 1: Female Patients’ Characteristics
Characteristic n = 874 (%)
Ethnicity
Malay 489 (55.9)
Chinese 175 (20.0)
Indian 174 (19.9)
Others 36 (4.1)
Age group
<65 495 (56.6)
≥ 65 379 (43.4)
Diabetes Mellitus
No 388 (44.4)
Yes 486 (55.6)
Hypertension
No 223 (25.5)
Yes 651 (74.5)
Smoking status
Never 786 (89.9)
Active/former 88 (10.1)
Dyslipidaemia
No 561 (64.2)
Yes 313 (35.8)
Family history of CVD
No 792 (90.6)
Yes 82 (9.4)
MI History
No 784 (89.7)
Yes 90 (10.3)
Chronic lung disease
No 859 (98.3)
Yes 15 (1.7)
Cerebrovascular disease
No 842 (96.3)
Yes 32 (3.7)
Peripheral vascular disease
No 870 (99.5)
Yes 4 (0.5)
Renal disease
No 832 (95.2)
Yes 42 (4.8)
Killip Class
Class I 521 (59.6)
Class II 219 (25.1)
Class III 44 (5.0)
Class IV 90 (10.3)
PCI
No 629 (72.0)
Yes 245 (28.0)
Cardiac catheterization
No 573 (65.6)
Yes 301 (34.4)
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Table 2: Variables in the Multivariate Model for Female Patients
Variable Posterior Mean SE OR (95% Credible Interval)
Dyslipidaemia −0.666 0.048 0.514 (0.310, 0.866)
MI History 0.626 0.062 1.870 (0.980, 3.490)
Smoking −0.984 0.089 0.374 (0.141, 0.979)
Renal disease 0.827 0.077 2.286 (1.026, 3.938)
Killip class II 0.851 0.054 2.342 (1.362, 3.088)
Killip class III 1.120 0.083 3.065 (1.274, 7.308)
Killip class IV 2.768 0.057 15.927 (9.291, 20.995)
Age (≥ 65) 1.079 0.045 2.942 (1.819, 4.731)
history, smoking, renal disease, Killip class and age group of the patients. The OR indicated
that female patients with dyslipidaemia were less likely to die (OR = 0.51). Besides, mortality
for female patients with MI history were 1.87 times higher than those without it. Surprisingly,
smoking patients were less likely to die than those non-smokers. The risk of death of those with
renal disease were 2.29 times more than those without it. As expected, patients in Killip class
IV were 15.9 times more likely to die than those from Killip class I. Also, risk of mortality was
2.94 times higher for female patients from the age group ≥ 65 than those from the age group
<65.
Results validation and model performance were performed using another 374 female pa-
tients’ datasets. Discrimination in the Bayesian model was considered good with an AUC of
0.8012. Also, the Hosmer-Lemeshow test showed a good fit as the p−value is greater than 0.05
5 Discussion
This study has shown that Bayesian approach was capable of developing a good prognostic
model and identifying the risk factors of CVD. Malaysia has an increasing prevalence of CVD
risk factors in the population. Six significant variables from the Bayesian model were associated
with the mortality of CVD female patients namely dyslipidaemia, MI, smoking, renal disease,
Killip class and age group of the patients.
Dyslipidemia is mostly prevalent in women, especially at post-menopausal age and it has
been closely related with CVD risk [18]. In line with the previous study, this study found that
dyslipidaemia is one of the significant risk factors of CVD among Malaysian women. Besides,
dyslipidaemia is always associated with obesity. As the degrees of obesity increase, there is an
increase likelihood of developing dyslipidaemia so thus CVD in women [19].
The next risk factor was MI history, the OR suggested that females with MI history were
more likely to die than those without it. This is similar with other studies, regardless of age,
within a year of the first MI, more women than men died, have heart failure, or suffered from
a stroke [20,21].
Smoking is always associated with a higher mortality risk [20-22]. However, in Malaysia this
is not always the case as the OR in this study suggested that those who were smoker were less
likely to die than non-smoker. This could be explained by a phenomenon called the smoker’s
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paradox where smokers had lower observed in-hospital mortality compared with nonsmokers
[23-25].
In this study, higher mortality risk was observed for patients with renal disease. This
is supported by other studies where renal disease or decreased kidney function is known as
an independent risk factor for the development of new CVD or worsening the existing CVD
[3,26,27]. Besides, patients in Killip class IV have higher risk of death as compared to patients
in Killip class I. This result was similar to previous studies worldwide where patients in Killip
class IV have higher number of admission and significantly higher in-hospital mortality rate
than the Killip I patients [28-31].
Other CVD risk factor is age where in this study, female patients with increasing age have
higher mortality. This is consistent with the findings of other studies whereby at older age or
post-menopausal age, women tend to have higher risk of dying as there is less protection from
the estrogen hormone [32,33]. In fact, each year CVD causes a larger number of deaths in older
women than in older men [32].
Adopting Bayesian approach allowed us to incorporate prior knowledge into the current
study. As in this study, non-informative prior was able to produced better prediction of risk
factors of CVD, similar results were found in previous studies [35-36]. Furthermore, Bayesian
approach provided more natural results and interpretations, especially in terms of being able
to make probability statements of the variables of interest [37].
Also, the credible interval produced by Bayesian analysis offered a more direct expression
of uncertainty [38]. However, there is a practical disadvantage of Bayesian approach whereby
the long computational time since iterative sampling techniques are used [39].
6 Conclusion
In conclusion, Bayesian logistic regression model provided a better understanding on the asso-
ciated risk factors of CVD for female patients which may help tailor prevention or treatment
plans more effectively.
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